www.imagineimagedesign.com • Professional Insights • Expert Commentary • Resource Center
www.imagineimagedesign.com

novel technologies for the production of bioactive peptides Affordable Options,production

Novel Technologies for the Production of Bioactive Peptides: Advancing Health and Industry by K Purohit·2024·Cited by 137—Phage display technologyis a method to identify potential novel therapeutic peptides by an intensive screening of a wide diversity of exogenous peptides 

novel technologies for the production of bioactive peptides

novel technologies for the production of bioactive peptides:technology

A
Howard Clark

researches 'novel technologies for the production of bioactive peptides' evolving digital environments and provides useful perspectives on Reddit and Telegram

Published on

Executive Summary

novel technologies for the production of bioactive peptides bioactive peptides by K Purohit·2024·Cited by 137—Phage display technologyis a method to identify potential novel therapeutic peptides by an intensive screening of a wide diversity of exogenous peptides 

The quest for potent and targeted therapeutic agents has increasingly focused on bioactive peptides. These short chains of amino acids, derived from various protein sources, exhibit a remarkable range of physiological activities, including antimicrobial, antioxidant, antihypertensive, and anticancer properties. While traditional methods like enzymatic hydrolysis have long been the cornerstone for production, the scientific community is actively exploring and implementing novel technologies to enhance efficiency, specificity, and sustainability in the production of these valuable compounds. This article delves into these cutting-edge technologies, examining their mechanisms, advantages, and the future they hold for the production of bioactive peptides.

Historically, the primary approach to generating bioactive peptides has involved breaking down larger proteins using specific enzymes in a process known as enzymatic hydrolysis. This method offers mild conditions and avoids harsh chemicals, making it a preferred choice for many applications. However, the demand for higher yields, greater purity, and the discovery of novel peptide sequences necessitates the exploration of advanced technologies.

Among the most promising novel technologies are those that leverage physical forces and non-thermal processing. Ultrasound and microwave technologies, for instance, are gaining traction for their ability to accelerate hydrolysis and improve extraction yields. High-pressure processing (HPP), also known as high-pressure processing, is another efficient, green technology that can disrupt cellular structures, facilitating the release of bioactive peptides from complex matrices. Similarly, pulsed electric field technology offers a non-thermal method for enhancing the release of bioactive peptides from food sources by applying high-voltage electric pulses. Subcritical water hydrolysis extraction (SWE) is also emerging as a sustainable technology, utilizing water at elevated temperatures and pressures to efficiently extract peptides.

Beyond these physical methods, advancements in biotechnology are revolutionizing peptide production. Recombinant DNA technology allows for the production of specific peptides within microbial or cellular systems, offering precise control over peptide sequence and quantity. This method for peptide therapeutics is particularly valuable for producing complex or difficult-to-synthesize peptides. Furthermore, microbial fermentation is being optimized with various microorganisms capable of endogenously expressing proteases, presenting an alternative to *in vitro* enzymatic hydrolysis. The use of multiple fermentations, as well as the combination of enzymatic hydrolysis with fermentation, has shown to increase the production of bioactive peptides.

The discovery of novel peptide sequences is also being accelerated by innovative computational approaches. Genome Mining, which analyzes an organism's genomic sequence using bioinformatics tools, can predict gene sequences that potentially encode bioactive peptides. This in silico approach significantly streamlines the identification of new peptide candidates before embarking on experimental validation. Another powerful tool in this regard is Phage display technology, a method that allows for the intensive screening of a vast diversity of exogenous peptides to identify potential novel therapeutic peptides. These computational and screening technologies are crucial for expanding the repertoire of known bioactive peptides and their potential applications.

The field is dynamic, with companies like Amide Technologies launching its novel peptide manufacturing platform to advance complex peptide synthesis. This highlights the commercial interest and investment in improving production technology for peptides. The development of novel bioactive peptides is not limited to specific sources; research spans from extracting them from dairy proteins and fish protein to exploring their potential in pharmaceuticals and food industries. For example, bioactive peptides derived from fish, such as those from Gadidae, have demonstrated potent bioactivities.

In conclusion, the landscape of bioactive peptides production is rapidly evolving, driven by the development and integration of novel technologies. From physical processing techniques like ultrasound and pulsed electric field technology to biotechnological approaches like recombinant DNA technology and advanced discovery tools such as Genome Mining and Phage display technology, these innovations are paving the way for more efficient, sustainable, and diverse production of bioactive peptides. This progress promises to unlock new therapeutic avenues and industrial applications, underscoring the importance of continued research and development in this exciting field. The ongoing exploration of novel peptides and their multifaceted functionalities ensures that bioactive peptides will continue to play a significant role in human health and well-being.

Related Articles

Frequently Asked Questions

Here are the most common questions about novel technologies for the production of bioactive peptides.

In comparison to enzymatic hydrolysis in vitro, fermentation with various microorganisms capable of endogenously expressing proteases represents an alternative 
Exploring the Potential of Bioactive Peptides: From Natural
Bioactive peptides are prepared mainly by enzymatic hydrolysis. High specificity, mild conditions, a lack of residual organic solvents and toxic chemicals in 
by MA Murtaza·2022·Cited by 62—This review emphasizes theproductionofpeptidesfrom the dairy proteins and discusses the potential use ofnovel technologiesas pretreatments.

Leave a Comment

Share your thoughts, feedback, or additional insights on this topic.

Explore More